SKINLITE CREAM 25G | Hydroquinone Tretinoin Mometasone Cream
SKINLITE CREAM 25G contains Hydroquinone 2%, Tretinoin 0.025%, and Mometasone 0.1%, a prescription dermatological cream used under supervision for melasma and hyperpigmentation management.
SKINLITE CREAM 25G
SKINLITE CREAM (HYDROQUINONE + TRETINOIN + MOMETASONE): Comprehensive Guide and Benefits
Introduction to SKINLITE CREAM
SKINLITE: Triple-Action Pigmentation Management Cream
SKINLITE CREAM contains Hydroquinone 2% w/w + Tretinoin 0.025% w/w + Mometasone Furoate 0.1% w/w, a dermatological combination medicine belonging to the topical depigmenting, retinoid, and corticosteroid drug class. It is prescribed for the short-term management of melasma and hyperpigmentation-related skin concerns under dermatologist supervision.
The formulation combines Hydroquinone, which helps reduce melanin production; Tretinoin, a retinoid that supports skin cell turnover; and Mometasone Furoate, a corticosteroid that helps reduce inflammatory responses associated with topical treatment.
SKINLITE CREAM is supplied as 1 tube containing 25g and is intended for external topical application only as directed by a healthcare professional.
Drug Class
Therapeutic Class: Dermatological Medication
Drug Class: Depigmenting Agent + Retinoid + Corticosteroid Combination
Pharmacological Class: Tyrosinase Inhibitor + Retinoid + Glucocorticoid
Generic Composition: Hydroquinone 2% w/w + Tretinoin 0.025% w/w + Mometasone Furoate 0.1% w/w
Key Benefits of SKINLITE CREAM 25G
Helps manage melasma and hyperpigmentation under medical supervision.
Supports reduction of dark patches and uneven skin tone.
Helps reduce excess melanin formation.
Supports skin renewal through retinoid activity.
Helps control inflammation associated with pigmentation treatment.
Provides targeted topical dermatological therapy.
How SKINLITE CREAM Works
Mechanism of Action
SKINLITE CREAM works through the combined action of three active ingredients:
Hydroquinone Action
Inhibits tyrosinase, an enzyme involved in melanin production.
Reduces excessive pigment formation.
Helps gradually improve the appearance of hyperpigmented areas.
Tretinoin Action
Promotes skin cell turnover.
Helps remove pigmented surface skin cells.
Supports improved skin texture and renewal.
Mometasone Furoate Action
Acts as a topical corticosteroid.
Helps reduce inflammatory activity and irritation.
Together, these actions support dermatologist-guided management of pigmentation disorders.
Usage Instructions for SKINLITE CREAM 25G
Use SKINLITE CREAM only as prescribed by your dermatologist.
Clean and dry the affected facial area before application.
Apply a thin layer to the affected pigmentation areas as directed.
Usually applied in the evening or according to medical advice.
Avoid contact with eyes, lips, and mucous membranes.
Use sunscreen regularly during treatment.
Do not continue prolonged use without medical supervision.
Medicinal Advantages of SKINLITE CREAM
Provides combination therapy for pigmentation concerns.
Targets multiple pathways involved in melasma management.
Helps improve the appearance of dark patches and uneven skin tone.
Supports controlled dermatologist-guided treatment plans.
Provides convenient topical cream application.
NOTE: SKINLITE CREAM is a prescription dermatological medicine and should be used only under dermatologist supervision.
Off-Label Uses of SKINLITE CREAM
Healthcare professionals may consider this combination for additional pigmentation-related conditions based on individual patient assessment and clinical judgement.
Disclaimer: Off-label use should only be considered by qualified healthcare professionals.
Expert Advice for Optimal Use
Apply only the prescribed quantity.
Follow the recommended treatment duration.
Use broad-spectrum sunscreen during daytime.
Avoid combining with other strong active skincare products without medical advice.
Inform your dermatologist about other topical medicines being used.
Precautions
External Use Only
Do not swallow or apply inside the eyes, mouth, or mucosal areas.
Steroid-Containing Formulation
Use only under medical supervision, especially for facial application and prolonged treatment.
Sun Exposure
Use sun protection during treatment to help reduce the risk of pigmentation returning.
Pregnancy & Breastfeeding
Consult your healthcare provider before use during pregnancy or breastfeeding.
Storage Instructions
Store below 25°C.
Keep the tube tightly closed after use.
Protect from direct sunlight and moisture.
Do not freeze.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is SKINLITE CREAM 25G used for?
A: SKINLITE CREAM is used under dermatologist supervision for short-term management of melasma and hyperpigmentation-related skin concerns.
Q: What are the active ingredients in SKINLITE CREAM?
A: It contains Hydroquinone 2%, Tretinoin 0.025%, and Mometasone Furoate 0.1%.
Q: How does SKINLITE CREAM work?
A: It works through Hydroquinone’s pigment-reducing action, Tretinoin’s skin renewal activity, and Mometasone’s anti-inflammatory effect.
Q: Is SKINLITE CREAM prescription-only?
A: Yes. It should be used under dermatologist guidance due to its active ingredients.
Q: How should SKINLITE CREAM be applied?
A: Apply a thin layer to affected pigmentation areas as directed by your dermatologist.
Q: Can SKINLITE CREAM be used for all dark spots?
A: No. It should only be used for pigmentation conditions diagnosed as suitable for this combination therapy.
Product Tags
SKINLITE Cream 25G, Hydroquinone Tretinoin Mometasone Cream, Melasma Treatment Cream, Hyperpigmentation Cream, Skin Pigmentation Medicine, Depigmenting Cream, Dark Spot Treatment Cream, Dermatology Cream, Prescription Skin Cream, Zydus SKINLITE Cream.
